KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Total Liabilities (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Total Liabilities for 16 consecutive years, with $34.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Liabilities fell 32.79% to $34.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $34.0 million, a 32.79% decrease, with the full-year FY2025 number at $34.0 million, down 32.79% from a year prior.
  • Total Liabilities was $34.0 million for Q4 2025 at Biolife Solutions, down from $38.3 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $88.4 million in Q1 2023 to a low of $31.2 million in Q1 2021.
  • A 5-year average of $62.4 million and a median of $68.2 million in 2022 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: surged 745.18% in 2021, then tumbled 37.66% in 2025.
  • Biolife Solutions' Total Liabilities stood at $76.2 million in 2021, then rose by 12.86% to $86.0 million in 2022, then fell by 12.77% to $75.1 million in 2023, then tumbled by 32.61% to $50.6 million in 2024, then tumbled by 32.79% to $34.0 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Total Liabilities are $34.0 million (Q4 2025), $38.3 million (Q3 2025), and $40.1 million (Q2 2025).